Combinatorial gene therapy accelerates bone regeneration: non-viral dual delivery of VEGF and BMP2 in a collagen-nanohydroxyapatite scaffold

Adv Healthc Mater. 2015 Jan 28;4(2):223-7. doi: 10.1002/adhm.201400397. Epub 2014 Aug 13.

Abstract

Vascularization and bone repair are accelerated by a series of gene-activated scaffolds delivering both an angiogenic and an osteogenic gene. Stem cell-mediated osteogenesis in vitro, in addition to increased vascularization and bone repair by host cells in vivo, is enhanced using all systems while the use of the nanohydroxyapatite vector to deliver both genes markedly enhances bone healing.

Keywords: bone regeneration; collagen scaffolds; gene-activated scaffolds; mesenchymal stem cells; non-viral gene therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Morphogenetic Protein 2 / administration & dosage
  • Bone Morphogenetic Protein 2 / pharmacology*
  • Bone Regeneration / drug effects*
  • Collagen / pharmacology*
  • Drug Delivery Systems*
  • Durapatite / pharmacology*
  • Gene Transfer Techniques
  • Genetic Therapy*
  • Human Umbilical Vein Endothelial Cells / drug effects
  • Humans
  • Mesenchymal Stem Cells / cytology
  • Mesenchymal Stem Cells / drug effects
  • Mice
  • Neovascularization, Physiologic / drug effects
  • Polyethyleneimine / pharmacology
  • Rats
  • Tissue Scaffolds / chemistry*
  • Vascular Endothelial Growth Factor A / administration & dosage
  • Vascular Endothelial Growth Factor A / pharmacology*
  • Wound Healing / drug effects

Substances

  • Bone Morphogenetic Protein 2
  • Vascular Endothelial Growth Factor A
  • nano-hydroxyapatite-collagen
  • Polyethyleneimine
  • Collagen
  • Durapatite